0001638599-18-000573.txt : 20180523 0001638599-18-000573.hdr.sgml : 20180523 20180523202342 ACCESSION NUMBER: 0001638599-18-000573 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180523 FILED AS OF DATE: 20180523 DATE AS OF CHANGE: 20180523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Biggar Stephen R CENTRAL INDEX KEY: 0001340380 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 18856389 MAIL ADDRESS: STREET 1: 860 WASHINGTON STREET 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 3 1 doc3_5428.xml PRIMARY DOCUMENT X0206 3 2018-05-23 1 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001340380 Biggar Stephen R 860 WASHINGTON STREET, 3RD FLOOR NEW YORK NY 10014 1 0 0 0 No securities are beneficially owned /s/ Stephen R. Biggar 2018-05-23